Two prostate cancer studies that will... - Advanced Prostate...

Advanced Prostate Cancer

21,020 members26,201 posts

Two prostate cancer studies that will pay you for your time, and will pay Malecare $100 for referring you.

Darryl profile image
DarrylPartner
0 Replies

Here are two prostate cancer studies that will pay you for your time, and will pay Malecare $100 for referring you. If you are interested, please complete the registration that is unique to Malecare: research.net/r/Malecare

Prostate Cancer Study #1 -mCRPC: Ten patients are needed for a 75 minute phone interview to review patient communications materials. Patients who have progressed to mCRPC are asked to contact us to discuss the study to determine if they are interested in scheduling the interviews. The dates of the actual study begin on Thursday, December 13 and participants are paid $125.

Prostate Cancer Study #2 - stages II-IV: Twenty patients and ten caregivers are needed for a 50 minute webcam interview on behalf of a healthcare company looking to bring better ideas and treatments to patients. This study also has a brief assignment to complete prior to the study and participants are paid $125.

If you are interested, please complete the registration that is unique to Malecare: research.net/r/Malecare

Written by
Darryl profile image
Darryl
Partner
To view profiles and participate in discussions please or .
Read more about...

You may also like...

$175 for interview plus $200 for follow-up

for phone interviews ($125 paid) If you are interested in learning more, please complete this...

$150 Online Research Opportunity

https://www.research.net/r/Malecare Pillar Patient Advocates is seeking 10 patients who are on their

48 Prostate Cancer Presentations - Malecare 2020

the Prostate Cancer Patient Conference schedule. 48 presentations. Please let me know what you...

Malecare is revenge against Prostate Cancer

become Malecare. My father died from prostate cancer in 2005. Malecare is my revenge. The...

New study on the value of EXERCISE for advanced prostate cancer

“This study provides strong evidence for the recommendation patients with prostate cancer, and...